2020 American Transplant Congress
Change in Hypertension (HTN) Guidelines in Living Kidney Donors (LKDs) and Long-Term Renal Outcomes
1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic Rochester, Scottsdale, AZ
*Purpose: There is limited knowledge regarding the long-term renal outcomes in hypertensive LKDs. We performed a multicenter study assessing long-term outcomes with or without HTN…2020 American Transplant Congress
Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Our purpose was to investigate the difference in outcomes between…2020 American Transplant Congress
Abdominal Multiorgan Retrieval from Pigs in a Slaughterhouse: A Reliable and Efficient Donation after Circulatory Death Model for Ex Vivo Organ Perfusion
Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom
*Purpose: Advances in organ perfusion technology have been driven by the increasing necessity to utilise organs from donors after circulatory death (DCD) and marginal donors.…2020 American Transplant Congress
Impact of Body Mass Index on Methodsof Assessing Glomerular Filtration Rate in Living Kidney Donors
*Purpose: The current Organ Procurement and Transplantation Network (OPTN) policy on living kidney donors (LKD) require that all LKD candidates have measured glomerular filtration rate…2020 American Transplant Congress
An Evaluation of Deceased Donor Eligibility and US Organ Donation Rates
*Purpose: Organ Procurement Organization (OPO) performance assessment is essential for identifying best practices and improvement opportunities. We aimed to evaluate OPO performance using the following…2020 American Transplant Congress
To Donate or Not to Donate? The Balancing Act of Apol-1 Genetic Testing in Potential Living Kidney Donors of African Descent in Resource Limited Countries
*Purpose: To report our findings of APOL-1 testing in individuasl of African descent presenting as potential living kidney donors in resource limited countries; Antigua and…2020 American Transplant Congress
Long Term Outcomes of Hypertensive Kidney Donors
Houston Methodist Hospital, Houston, TX
*Purpose: Many people with hypertension are excluded from kidney donation fearing that hypertension is a major cause of CKD and its impact maybe magnified after…2020 American Transplant Congress
Using Personal Contact with Donors and Recipients to Bridge Disparities in Native American Organ Donation and Transplantation
1UCSF, San Francisco, CA, 2Yale, New Haven, CT
*Purpose: Native Americans (NAs) are 3.5 times more likely to suffer from end-stage renal disease than White Americans, yet are 34% less likely to receive…2020 American Transplant Congress
Delayed Introduction of Mammalian Inhibitors of Rapamycin (mTOR) Post Kidney Transplantation Might Avoid the Chronic Nephrotoxicity of Calcineurin Inhibitors. Herein We Are Reporting an Eight-Years Single Center Experience of mTOR-Based Immunosuppression Regimen in Comparison with Cyclosporin-Based Regimen
*Purpose: Delayed introduction of mTOR inhibitors post kidney transplantation might avoid the chronic nephrotoxicity of CNI: eight-years single center experience.*Methods: This is a retrospective analysis…2020 American Transplant Congress
The Next Era of Living Kidney Donation for Renal Transplantation: Virtual Postoperative Follow-Up
Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Living kidney donation (LKD) offers the best long-term outcomes for patients undergoing kidney transplantation. However, LKD has been declining in the U.S. in recent…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 90
- Next Page »